Updated Jul 16, 2026
ROBERTSON MICHELLE has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $19K.
Michelle Robertson is associated with Geron Corporation, a biotechnology company focused on developing therapies for cancer. Specific details about her role or contributions to the company are not widely documented in public sources.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | VSTM | Verastem, Inc. | A — Grant or award | 36.0K | $0.00 | |
| 2026-02-19 | GERN | GERON CORP | S — Open-market sale | 9.9K | $1.94 | $19K |
| 2026-02-19 | GERN | GERON CORP | M — Option exercise | 27.5K | $0.00 |
Michelle Robertson is associated with Geron Corporation, a biotechnology company focused on developing therapies for cancer. Specific details about her role or contributions to the company are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($19K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ROBERTSON MICHELLE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.